Table 1 Preoperative baseline and characteristics among the mortality and control groups
Variable | Control (n = 238) | Mortality (n = 174) | p value |
|---|---|---|---|
Age (year) | 57.99 ± 12.34 | 61.59 ± 11.77 | 0.003 |
Gender (male, %) | 160, 67 | 110, 63 | 0.398 |
Weight (kg) | 64.26 ± 12.36 | 63.16 ± 10.52 | 0.343 |
NYHA class (n, %) | Â | Â | 0.238 |
I | 8, 3 | 6, 3 | Â |
II | 66, 28 | 60, 34 | Â |
III | 142, 60 | 92, 53 | Â |
IV | 22, 9 | 16, 9 | Â |
EuroSCORE | 4.85 ± 2.37 | 7.11 ± 2.18 | < 0.001 |
Echocardiogram variables | Â | Â | Â |
Preoperative LVEF (%) | 30.84 ± 3.97 | 31.02 ± 4.03 | 0.640 |
Preoperative LVDd (cm) | 7.04 ± 1.10 | 6.95 ± 1.03 | 0.374 |
Evaluated PAP (mmHg) | 46.64 ± 13.49 | 49.78 ± 15.52 | 0.048 |
Previous medical History (n, %) | Â | Â | Â |
Acute myocardial infarction | 61, 26 | 39, 22 | 0.452 |
Atrial fibrillation | 56, 24 | 39, 22 | 0.791 |
Diabetes mellitus | 26, 11 | 20, 11 | 0.856 |
Chronic renal disease | 4, 2 | 3, 2 | 0.937 |
Hypertension | 65, 27 | 41, 24 | 0.390 |
Liver diseases | 8, 3 | 6, 3 | 0.962 |
COPD | 15, 6 | 4, 2 | 0.056 |
Cancer | 3, 1 | 3, 2 | 0.698 |
Smoking | 46, 19 | 35, 20 | 0.843 |
Excessive alcohol | 20, 8 | 15, 9 | 0.938 |
Iodine contrast medium use | 228, 96 | 169, 97 | 0.768 |
Vancomycin use | 4, 2 | 2, 1 | 0.658 |
Gentamicin use | 0 | 0 | — |
Others renal-injury drug | 2, 1 | 5, 3 | 0.115 |